Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich, ActivX Biosciences

Premium
Sigma-Aldrich last week launched the Panorama Antibody Microarray XPRESS Profiler 725 high-throughput tool for multiplex protein expression profiling of serum, cell, and tissue extracts.
 
Panorama contains 725 highly specific antibodies arrayed in duplicate nitrocellulose slides that are compatible with most DNA array sequences, the company said in a statement. The array antibodies detect human, mouse, and rat proteins associated with key cell signaling and gene regulation pathways.
 

 
ActivX Biosciences this week launched the KiNativ proprietary platform for profiling protein kinases and the analysis of kinase inhibitors. KiNative has a profiling capability of 430 kinases, the company said in a statement

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.